Literature DB >> 16881110

Hypothalamic-pituitary-adrenal hormonal responses to exercise stress test in patients with rheumatoid arthritis compared to healthy controls.

Yesim Kurtais1, Birkan Sonel Tur, Atilla Halil Elhan, Murat Faik Erdogan, Peyman Yalçin.   

Abstract

OBJECTIVE: There is controversy about hormonal dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis that is supposed to contribute to the development or persistence of rheumatoid arthritis (RA). We investigated whether there is an altered and blunted response of the HPA axis when stimulated by exercise stress in patients with RA.
METHODS: Twenty women with RA and 15 matched healthy controls were included in the study. All subjects took an ergospirometric exercise test on the treadmill to determine anaerobic threshold (AT). On another day, blood was collected for basal plasma levels of growth hormone (GH), insulin-like growth factor-I, cortisol, and adrenocorticotrophic hormone (ACTH); and subjects exercised on treadmill at an intensity above their AT. Blood was collected again to measure hormone levels just after the exercise stopped and 60 minutes later.
RESULTS: Two subjects left the study, so 19 patients and 14 controls were evaluated. Peak oxygen consumption (VO(2)), VO(2) at AT, exercise test duration, and basal hormone levels were similar in groups. In both groups, GH slightly increased just after the exercise (0 min), and decreased at 60 min compared to baseline, but the change was not different between groups. Cortisol levels decreased significantly at 0 and 60 min in both groups, ACTH levels did not change in time, and there was no difference between groups.
CONCLUSION: There was no perturbation in HPA axis stimulated by exercise stress test in patients with RA and all the variables measured were similar to those of the control group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16881110

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Impaired hypothalamo-pituitary-adrenal axis in patients with ankylosing spondylitis.

Authors:  L Kebapcilar; O Bilgir; A Alacacioglu; Y Yildiz; A Taylan; R Gunaydin; A Yuksel; B Karaca; I Sari
Journal:  J Endocrinol Invest       Date:  2009-07-20       Impact factor: 4.256

Review 2.  Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses.

Authors:  Sabine J M de Brouwer; Floris W Kraaimaat; Fred C G J Sweep; Marjonne C W Creemers; Timothy R D J Radstake; Antoinette I M van Laarhoven; Piet L C M van Riel; Andrea W M Evers
Journal:  Arthritis Res Ther       Date:  2010-05-17       Impact factor: 5.156

3.  Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal response in patients with fibromyalgia syndrome?

Authors:  Aysun Genc; Birkan Sonel Tur; Yesim Kurtais Aytur; Derya Oztuna; Murat Faik Erdogan
Journal:  J Phys Ther Sci       Date:  2015-07-22

4.  Aerobic capacity over 16 years in patients with rheumatoid arthritis: Relationship to disease activity and risk factors for cardiovascular disease.

Authors:  Kristina Hörnberg; Björn Sundström; Lena Innala; Solbritt Rantapää-Dahlqvist; Solveig Wållberg-Jonsson
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

5.  Enhanced reactivity to pain in patients with rheumatoid arthritis.

Authors:  Robert R Edwards; Ajay D Wasan; Clifton O Bingham; Joan Bathon; Jennifer A Haythornthwaite; Michael T Smith; Gayle G Page
Journal:  Arthritis Res Ther       Date:  2009-05-04       Impact factor: 5.156

Review 6.  Are persons with rheumatoid arthritis deconditioned? A review of physical activity and aerobic capacity.

Authors:  Tjerk Munsterman; Tim Takken; Harriet Wittink
Journal:  BMC Musculoskelet Disord       Date:  2012-10-18       Impact factor: 2.362

7.  Smooth Muscle-Specific BCL6+/- Knockout Abrogates Sex Bias in Chronic Hypoxia-Induced Pulmonary Arterial Hypertension in Mice.

Authors:  Yang-Ming Yang; Pravin B Sehgal
Journal:  Int J Endocrinol       Date:  2018-07-24       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.